Prostatype Genomics AB (OSTO:PROGEN) Dividend
Prostatype Genomics AB (OSTO:PROGEN) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -421%. View its historical dividend record below and compare with dividend-paying peers.
Frequently Asked Questions: OSTO:PROGEN Dividend
Does Prostatype Genomics AB (OSTO:PROGEN) pay a dividend?
Prostatype Genomics AB (OSTO:PROGEN) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.
Why doesn't Prostatype Genomics AB pay a dividend?
Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Prostatype Genomics AB has returned capital to shareholders via buybacks at a rate of -421% over the past 3 years.
What are dividend-paying alternatives to Prostatype Genomics AB?
For dividend-paying alternatives in Prostatype Genomics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.